Charles Schwab’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-273,002
Closed -$1.15M 3757
2023
Q1
$1.15M Buy
273,002
+2,901
+1% +$15.1K ﹤0.01% 2692
2022
Q4
$1.62M Buy
270,101
+12,405
+5% +$67.7K ﹤0.01% 2627
2022
Q3
$1.5M Buy
257,696
+16,684
+7% +$104K ﹤0.01% 2665
2022
Q2
$1.44M Buy
241,012
+203,516
+543% +$1.04M ﹤0.01% 2663
2022
Q1
$176K Hold
37,496
﹤0.01% 3328
2021
Q4
$93K Hold
37,496
﹤0.01% 3444
2021
Q3
$111K Buy
37,496
+17,496
+87% +$47.7K ﹤0.01% 3371
2021
Q2
$50K Hold
20,000
﹤0.01% 3372
2021
Q1
$59K Hold
20,000
﹤0.01% 3425
2020
Q4
$65K Buy
+20,000
New +$66.5K ﹤0.01% 3341
2019
Q2
Sell
-95,500
Closed -$93K 3334
2019
Q1
$93K Hold
95,500
﹤0.01% 3096
2018
Q4
$71K Hold
95,500
﹤0.01% 3114
2018
Q3
$207K Sell
95,500
-14,337
-13% -$35.5K ﹤0.01% 3074
2018
Q2
$547K Buy
+109,837
New +$481K ﹤0.01% 2778
2016
Q2
Sell
-39,370
Closed -$210K 3225
2016
Q1
$210K Buy
39,370
+9,620
+32% +$76.9K ﹤0.01% 2887
2015
Q4
$366K Buy
29,750
+10,670
+56% +$142K ﹤0.01% 2785
2015
Q3
$279K Hold
19,080
﹤0.01% 2861
2015
Q2
$373K Hold
19,080
﹤0.01% 2790
2015
Q1
$346K Hold
19,080
﹤0.01% 2780
2014
Q4
$451K Hold
19,080
﹤0.01% 2658
2014
Q3
$462K Hold
19,080
﹤0.01% 2620
2014
Q2
$537K Hold
19,080
﹤0.01% 2599
2014
Q1
$649K Buy
19,080
+3,020
+19% +$103K ﹤0.01% 2489
2013
Q4
$309K Hold
16,060
﹤0.01% 2795
2013
Q3
$267K Hold
16,060
﹤0.01% 2805
2013
Q2
$160K Buy
+16,060
New +$188K ﹤0.01% 2979

Other funds holding CTIC